Inovio Pharmaceuticals, Inc. – Value Analysis (NASDAQ:INO) : April 26, 2017
Categories: Fundamental Analysis Yahoo FinanceClick here to see latest analysis Capitalcube gives Inovio Pharmaceuticals, Inc. a score of 21. Our analysis is based on comparing Inovio Pharmaceuticals, Inc. with the following peers – Novartis AG Sponsored ADR, Pfizer Inc., Johnson & Johnson, Arrowhead Pharmaceuticals, Inc., GlaxoSmithKline plc Sponsored ADR, Merck & Co., Inc., Abeona Therapeutics, Inc., Cleveland BioLabs, Inc., ... Read more (Read more...)